Scholars suggest disruption of the RP‐MDM2‐p53 pathway accelerates APC loss‐induced colorectal tumorigenesis, yet how much APC loss can simulate CTNNB1 mutation in the ACC context remains undetermined. The gene discussed is TP53; the disease is adrenal cortex carcinoma.